Loading...
•
Dec 31, 2025
AptarGroup Q4 2025 Earnings Report
AptarGroup reported a 14% increase in sales and a 26% decrease in net income for the fourth quarter of 2025.
Key Takeaways
AptarGroup, Inc. reported a strong 14% increase in reported sales and 5% core sales growth in the fourth quarter of 2025, with all three segments contributing to core sales growth. However, reported net income decreased by 26% to $74 million, and adjusted EBITDA margin was 19.8%, down from 23.0% in the prior year, primarily due to product mix and higher production costs.
Reported sales increased 14% to $963 million, with core sales up 5% across all segments.
Reported net income decreased 26% to $74 million, and reported earnings per share fell 24% to $1.13.
Adjusted EBITDA margin was 19.8%, a decrease from 23.0% in the prior year, impacted by product mix and production costs.
The company returned $206 million to shareholders through share repurchases and dividends and approved a new $600 million share repurchase authorization.
Revenue by Segment
Forward Guidance
Aptar expects adjusted earnings per share for the first quarter of 2026 to be in the range of $1.13 to $1.21, assuming an effective tax rate of 21.0% to 23.0% and a 1.18 Euro to USD exchange rate. Capital investments are projected to be between $260 million and $280 million.
Positive Outlook
- Strong growth expected within Pharma, excluding emergency medicine, with continued growth in injectables, systemic nasal drug delivery, and consumer healthcare solutions.
- Early signs of strengthening demand in prestige fragrance within the Beauty segment.
- Steady performance anticipated in the Closures segment driven by innovation and category conversion.
- Commitment to driving further productivity gains and maintaining a strong balance sheet.
- Ability to return capital to shareholders while retaining strategic flexibility and investing for long-term value creation.
Challenges Ahead
- Emergency medicine within Pharma is expected to go through a period of destocking.
- The guidance assumes a specific Euro to USD exchange rate (1.18), which could fluctuate.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...